| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $101.0M | +50.6% |
| SG&A Expense | $26.1M | +28.8% |
| Operating Income | -$127.1M | -48.1% |
| Pre-tax Income | -$116.8M | -39.3% |
| Net Income | -$116.8M | -39.3% |
| EPS (Basic) | -$3.05 | -18.2% |
| EPS (Diluted) | -$3.05 | -18.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.5M | +21.9% |
| Short-term Investments | $111.4M | -47.0% |
| Current Assets | $161.8M | -36.0% |
| Total Assets | $173.3M | -34.9% |
| Current Liabilities | $21.8M | +53.5% |
| Total Liabilities | $26.3M | +25.0% |
| Stockholders' Equity | $147.0M | -40.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$97.0M | -37.1% |
| Capital Expenditures | $1.1M | +33.1% |
| Investing Cash Flow | $104.1M | +328.9% |
| Financing Cash Flow | $1.4M | -98.9% |
| Free Cash Flow | -$98.2M | -37.1% |